Depressive symptomatology | ||||
---|---|---|---|---|
Independent variables | Sample (n = 792) | Only insulin (n = 252) | Only sulfonylurea (n = 562) | Combination therapy (n = 71) |
Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) | |
Age (years) | 0.97 (0.94–0.99)* | 0.97 (0.94–1.1) | 0.97 (0.95–1.00) | 0.99 (0.92–1.06) |
Male gender | 0.67 (.43–1.05) | 0.99 (0.47–2.1) | 0.48 (0.28–0.82)* | 0.62 (0.16–2.36) |
Health related quality of life | 0.97 (0.96–0.98)* | 0.97 (0.95–0.99)* | 0.97 (0.96–0.98)* | 0.95 (0.91–0.99)* |
ADLs causing problems | 0.87 (0.71–1.1) | 0.83 (0.59–1.12) | 0.83 (0.61–1.15) | 0.64 (0.23–1.71) |
IADLs causing problems | 1.31 (1.14–0.52)* | 1.24 (1.01–1.53)* | 1.29 (1.07–1.56)* | 1.31(0.82–2.08) |
No of Prescription | 1.02 (0.77–1.35) | 2.06 (0.90–4.72) | 0.91 (0.68–1.23) | 0.79 (0.23–2.71) |
Hospitalizations during previous year | 0.93 (.64–1.28) | 1.28 (0.80–2.05) | 0.58 (0.35–0.95)* | 0.81 (0.31–2.08) |
ER visits during previous year | 1.22 (0.90–1.66) | 1.10 (0.68–1.78) | 1.51 (1.04–2.18)* | 1.06 (0.49–2.26) |
Insulin therapy | 0.88 (0.31–2.52) | - | - | - |
Sulfonylurea therapy | 1.49 (0.55–4.03) | - | - | - |
Combination therapy | 1.66 (0.54–5.12) | - | - | - |